Logo 11 Sep 2025

Quick take | Washington’s fear of Chinese biotech could be just what Beijing needs

Subscribe to keep reading.

Trivium Tech keeps you briefed on the latest developments in China tech policy.

Try it free

Already a subscriber? Log in.

The Trump administration is considering an executive order (E.O.) that would block US pharma companies from buying Chinese-developed drug candidates.  Per the New York Times:

“At the heart of the possible clampdown is a drafted executive order that threatens to cut off the pipeline of Chinese-inven...



More recent developments

Logo April 28, 2026
Longread | Beijing pulls a new lever on the Meta-Manus deal

On April 27, China's macro-planning agency, the National Development and Reform Commission (NDRC) issued a notice ordering the parties to the Meta-Manus deal to unwind the transaction. Some context: Back in January, we told readers that Beijing was clearly intending… Read More »

Logo January 9, 2026
Will Beijing meddle in the Meta-Manus deal?

On December 29, Meta announced it would acquire Chinese AI startup Manus AI – reportedly for USD 2.5 billion. Inside China, the deal was widely applauded as a canonical home run: a blockbuster exit for startup founders who built a… Read More »

Logo October 29, 2025
Quick take | Is China angling to become the world’s lab partner?

Premier Li Qiang wants East Asian countries to participate in more research collaborations. That was the spirit of the speech he delivered on October 27 at the 28th ASEAN Plus China, Japan, and South Korea Summit. What caught our eye:… Read More »